Literature DB >> 15734996

Haploinsufficiency for odc modifies mouse skin tumor susceptibility.

Yongjun Guo1, John L Cleveland, Thomas G O'Brien.   

Abstract

Numerous studies have linked overexpression of ornithine decarboxylase (Odc) gene with enhanced susceptibility to mouse skin tumorigenesis. However, there is little experimental evidence suggesting that modest reductions in Odc expression might reduce tumor susceptibility. To address this issue, here we report the use of the Odc(+/-) haploinsufficiency model, in which one copy of the murine Odc gene has been inactivated by a homologous recombination. Compared with Odc(+/+) mice, Odc(+/-) mice exhibit reduced epidermal ODC enzyme activity and polyamine accumulation following treatment with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). Furthermore, following chronic TPA treatment, the characteristic hyperplastic response of the epidermis was diminished in Odc(+/-) mice. Finally, when subjected to a two-stage initiation-promotion protocol, substantially fewer skin papillomas developed in Odc(+/-) mice compared with wild-type littermates. These results support the concept that differences in tissue polyamine levels, resulting from either overexpression or reductions in ODC, are important modifiers of tumor susceptibility.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734996     DOI: 10.1158/0008-5472.CAN-04-3244

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

Review 1.  Mammalian polyamine metabolism and function.

Authors:  Anthony E Pegg
Journal:  IUBMB Life       Date:  2009-09       Impact factor: 3.885

2.  Association between the ornithine decarboxylase G316A polymorphism and breast cancer survival.

Authors:  Linping Xu; Jianping Long; Peng Wang; Kangdong Liu; Ling Mai; Yongjun Guo
Journal:  Oncol Lett       Date:  2015-05-12       Impact factor: 2.967

Review 3.  Current status of the polyamine research field.

Authors:  Anthony E Pegg; Robert A Casero
Journal:  Methods Mol Biol       Date:  2011

Review 4.  Polyamines and cancer: implications for chemotherapy and chemoprevention.

Authors:  Shannon L Nowotarski; Patrick M Woster; Robert A Casero
Journal:  Expert Rev Mol Med       Date:  2013-02-22       Impact factor: 5.600

5.  S-adenosylmethionine decarboxylase overexpression inhibits mouse skin tumor promotion.

Authors:  Chenxu Shi; Timothy K Cooper; Diane E McCloskey; Adam B Glick; Lisa M Shantz; David J Feith
Journal:  Carcinogenesis       Date:  2012-05-19       Impact factor: 4.944

6.  The TCA cycle transferase DLST is important for MYC-mediated leukemogenesis.

Authors:  N M Anderson; D Li; H L Peng; F J F Laroche; M R Mansour; E Gjini; M Aioub; D J Helman; J E Roderick; T Cheng; I Harrold; Y Samaha; L Meng; A Amsterdam; D S Neuberg; T T Denton; T Sanda; M A Kelliher; A Singh; A T Look; H Feng
Journal:  Leukemia       Date:  2016-02-15       Impact factor: 11.528

7.  Ornithine decarboxylase, the rate-limiting enzyme of polyamine synthesis, modifies brain pathology in a mouse model of tuberous sclerosis complex.

Authors:  David Kapfhamer; James McKenna; Caroline J Yoon; Tracy Murray-Stewart; Robert A Casero; Michael J Gambello
Journal:  Hum Mol Genet       Date:  2020-08-11       Impact factor: 6.150

8.  Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma.

Authors:  Robert J Rounbehler; Weimin Li; Mark A Hall; Chunying Yang; Mohammad Fallahi; John L Cleveland
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

Review 9.  Polyamine metabolism and cancer: treatments, challenges and opportunities.

Authors:  Robert A Casero; Tracy Murray Stewart; Anthony E Pegg
Journal:  Nat Rev Cancer       Date:  2018-11       Impact factor: 60.716

10.  Herbacetin suppresses cutaneous squamous cell carcinoma and melanoma cell growth by targeting AKT and ODC.

Authors:  Dong Joon Kim; Mee-Hyun Lee; KangDong Liu; Do Young Lim; Eunmiri Roh; Hanyong Chen; Sung-Hyun Kim; Jung-Hyun Shim; Myoung Ok Kim; Wenwen Li; Fayang Ma; Mangaladoss Fredimoses; Ann M Bode; Zigang Dong
Journal:  Carcinogenesis       Date:  2017-10-26       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.